HIGHLIGHTS
- who: Vaibhavi B. Wasnik and colleagues from the Opthalmology, Medical College, Datta Meghe Institute of Medical Sciences (DMIMSU) have published the paper: Received 08/08/2022 Review began 08/11/2022 Review ended 09/09/2022 Published 09/24/2022, in the Journal: (JOURNAL) of September/24,/2022
- what: The aim of this clinical trial was to check the safety of the gene product and the recovery of vision. The aim of the therapy here is to preserve the functions of the cones. The results of this trial had a dose-related effect.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.